Impact Factor 2024

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Emergency management of patients being treated with oral anticoagulants

Franco Manzato, Massimo Franchini

234-241

17-12-2013

https://doi.org/10.4081/itjm.2013.234

1085

PDF: 844

HTML: 304
Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry

Luca Masotti, Rinaldo Innocenti, Stefano Spolveri, Irene Chiti, Grazia Panigada, Cristiana Seravalle, Giancarlo Landini, Alberto Fortini, Rino Migliacci, Raffaele Laureano, for Tuscan FADOI Stroke Registry Investigators

134-140

12-06-2014

https://doi.org/10.4081/itjm.2014.450

1576

PDF: 1227

Appendix: 568

HTML: 622
Characteristics and clinical management of acute pulmonary embolism in real world: findings from TUSCAN-PE study

Luca Masotti, Filippo Pieralli, Grazia Panigada, Francesco Corradi, Rino Migliacci, Salvatore Lenti, Alessandro Tafi, Carlo Nozzoli, Giancarlo Landini, for TUSCAN-PE Investigators

125-133

03-06-2014

https://doi.org/10.4081/itjm.2014.504

2108

PDF: 1320

Appendix: 1088

HTML: 756
Proton pump inhibitors overuse: only inappropriate prescriptions or further iatrogenic damage?

Mario Visconti

217-228

22-09-2015

https://doi.org/10.4081/itjm.2015.562

2688

PDF: 1089

HTML: 2175
The incidence of bleeding in patients with nonvalvular atrial fibrillation using anticoagulants: a real-world report with the biggest Vietnamese data

Bui The Dung, Cao Ngoc Mai Han, Tran Hoa, Nguyen Thanh Hien

17-02-2025

https://doi.org/10.4081/itjm.2025.1807

1845

PDF: 290

HTML: 1
Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

Tommaso Sacquegna, Anna Zaniboni, Andrea Rubboli, Gaetano Procaccianti, Michela Crisci, Fabiola Maioli, Giorgia Arnone, Giuseppe Di Pasquale

314-322

15-12-2015

https://doi.org/10.4081/itjm.2015.468

1957

PDF: 899

HTML: 1232
Direct oral anticoagulants in real practice: which doses for which patients. Limitations and bleeding risk compared to vitamin K antagonists

Giancarlo Landini, Luca Masotti

41-47

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.41

915

PDF: 798
The practical management of bleedings during treatment with direct oral anticoagulants: the emergency reversal therapy

Luca Masotti, Giancarlo Landini, Grazia Panigada

48-58

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.48

1377

PDF: 935
Clinical case and short review of extreme short bowel syndrome: an update 21 years after

Pasquale Mansueto, Aurelio Seidita, Salvatore Iacono, Antonio Carroccio

45-51

22-03-2016

https://doi.org/10.4081/itjm.2016.543

1726

PDF: 902

HTML: 1273
D-dimer: a useful tool in gauging optimal duration of oral anticoagulant therapy?

M. Silingardi, A. Pizzini, I. Iori

45-47

03-05-2013

https://doi.org/10.4081/itjm.2007.2.45

958

PDF: 2390
Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study

Cecilia Politi, Tiziana Ciarambino, Letizia Riva, Stefania Frasson, Donata Lucci, Gualberto Gussoni, Lucio Gonzini, Mauro Campanini, Michele Gulizia, Giuseppe Di Pasquale, Giovanni Mathieu, on behalf of ATA-AF Steering Committee and Investigators

207-212

16-02-2016

https://doi.org/10.4081/itjm.2016.649

1701

PDF: 1452

Appendix: 669

HTML: 544
A review on management of antiphospholipid syndrome in clinical practice

Carmine Siniscalchi, Pietro Rossetti, Gaetano Carolla, Pierpaolo Di Micco, Adriano Stella, Michele Riva

13-09-2023

https://doi.org/10.4081/itjm.2023.1649

2544

PDF: 1027

HTML: 82
Pregnancy and heart disease: what Internists should know

Riccardo Gerloni, Domenico Panuccio

288-304

11-09-2017

https://doi.org/10.4081/itjm.2017.815

1336

PDF: 666

HTML: 265
The treatment of venous thromboembolism with new oral anticoagulants

Davide Imberti

29-35

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.29

1066

PDF: 835
Apixaban

Gianluca Airoldi, Mauro Campanini

128-134

07-03-2013

https://doi.org/10.4081/itjm.2011.128

1170

PDF: 1853
Assessment and predictors of inappropriate dose of direct oral anticoagulants

Mosaad O. Almegren

09-01-2024

https://doi.org/10.4081/itjm.2024.1679

901

pdf: 423

HTML: 124
The FADOI (Federation of Associations of Hospital Doctors on Internal Medicine) position paper on cardiovascular prevention in the higher risk complex patients

Mauro Campanini, Giuliano Pinna, Roberto Nardi, on behalf of the FADOI Cardiovascular Prevention Position Statements Group

387-404

15-12-2015

https://doi.org/10.4081/itjm.2015.669

2095

PDF: 870

Appendix: 465

HTML: 1459
Pharmacological interactions in novel oral anticoagulants, statins, and hypertension drugs in patients treated with direct-acting antivirals for hepatitis C: a Delphi Consensus project

Ivan Gentile, Giancarlo Agnelli, Angelo Avogaro, Claudio Borghi, Alessia Ciancio, Ernesto Claar, Patrizio Pasqualetti, Pasquale Perrone Filardi

25-11-2024

https://doi.org/10.4081/itjm.2024.1846

993

PDF: 349

SUPPLEMENTARY MATERIAL: 219

ACKNOWLEDGMENTS: 208

HTML: 109
In-hospital gastric protection with proton pump inhibitors: adverse effects beyond (over)utilization?

Paolo Montanari

51-56

30-04-2013

https://doi.org/10.4081/itjm.2010.51

810

PDF: 1009
New oral anticoagulants: key messages for clinicians

Matteo Giorgi-Pierfranceschi, Chiara Cattabiani, Francesco Dentali

74-84

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.74

1263

PDF: 872
Clinical characteristics of italian patients with venous thromboembolism enrolled in the RIETE Registry

Pierpaolo Di Micco, Alessandra Bura-Riviere, Renzo Poggio, Eros Tiraferri, Roberto Quintavalla, Adriana Visona, Paolo Prandoni, Maurizio Ciammaichella, Giovanni Barillari, RIETE Investigators

255-260

02-01-2012

https://doi.org/10.4081/itjm.2011.255

1046

PDF: 988
Doing more does not mean doing better: the FADOI contribution to the Slow Medicine program for a sustainable and wise healthcare system

Luigi Lusiani, Roberto Frediani, Roberto Nardi, Andrea Fontanella, Mauro Campanini

281-286

22-09-2015

https://doi.org/10.4081/itjm.2015.580

1504

PDF: 902

Appendix: 568

HTML: 431
Segmental arterial mediolysis: a challenging diagnosis in internal medicine

Giulia Bombardieri, Alessandra Rustici, Michele Caselli, Chiara Chirico, Veronica Bocchi, Andrea Montagnani

27-09-2024

https://doi.org/10.4081/itjm.2024.1795

488

PDF: 226

HTML: 99
Young FADOI and gender medicine: sex gender differences in cardiovascular disease

Tiziana Ciarambino, Miriam Gino, Paola Gnerre, Elena Barbagelata, Nunzia Barone, Francesca Saladini, Federica Lorenzi, Marta Zanon, Maria Cristina Pasquini, Cecilia Politi

23-31

20-03-2018

https://doi.org/10.4081/itjm.2018.864

2648

PDF: 1120

HTML: 479
Too many dangerous allergies

Stefania Scarlini, Fabrizio Turrini, Antonella Caronna, Roberto Messora, Luca Sarti, Goretta Bonacorsi, Marco Bondi

51-55

25-10-2013

https://doi.org/10.4081/itjm.2013.390

1851

PDF: 926

HTML: 341
Asymptomatic superior mesenteric vein thrombosis as unusual complication of acute cytomegalovirus infection: a case report

Michele Bertoni, Filippo Risaliti, Alessandra Giani, Emanuele Calabrese, Massimo Edoardo Di Natale

147-150

05-10-2015

https://doi.org/10.4081/itjm.2015.596

1547

PDF: 836

HTML: 464
Thrombophilias: therapeutic employment of direct oral anticoagulants in venous hypercoagulable states

Federico Cacciapuoti

136-142

17-09-2020

https://doi.org/10.4081/itjm.2020.1296

808

PDF: 513

HTML: 361
Liver diseases and pregnancy

Pietro Crispino, Luca Fontanella, Paola Gnerre

278-287

11-09-2017

https://doi.org/10.4081/itjm.2017.817

1480

PDF: 772

HTML: 297
Autoimmune liver diseases: internist's guide from bench to bedside

Mario Visconti

20-36

20-03-2015

https://doi.org/10.4081/itjm.2015.508

1762

PDF: 1068

HTML: 2260
Monitoring strategies for patients treated with the new oral anticoagulants and the need for laboratory evaluation of hemostasis

Andrea Fontanella, Pierpaolo Di Micco

59-64

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.59

926

PDF: 901
Optimal duration of anticoagulant therapy in patients with venous thromboembolism

Gualtiero Palareti

235-244

14-09-2018

https://doi.org/10.4081/itjm.2018.1077

1484

PDF: 1754

HTML: 260
Effects of the availability of new oral anticoagulants in patients with non-valvular atrial fibrillation in the real world: the NAIF study

Francesco Ventrella, Franco Mastroianni, Sergio Cappello, Luigi Iamele, Samantha Errico, Massimo Errico

176-183

06-07-2016

https://doi.org/10.4081/itjm.2016.715

1462

PDF: 923

HTML: 342
Screening of the key genes and signaling pathways for schizophrenia using bioinformatics and next generation sequencing data analysis

Iranna Kotturshetti, Basavaraj Vastrad, Veena Kori, Chanabasayya Vastrad, Shivakumar Kotrashetti

18-12-2024

https://doi.org/10.4081/itjm.2024.1830

1720

PDF: 366

SUPPLEMENTARY MATERIAL: 169

HTML: 15

1 - 33 of 33 items

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy